Santen Pharmaceutical Co., Ltd.
Text Size
S
M
L
For Patients
For
Patients
EMEA
Asia
Japan
Investors
Investors
Management Policies
Financial Summary
Latest IR Documents
IR Library
Other IR Information
Stock Information
IR Contact
Corporate Governance
Partnering
Partnering
Areas of Interest
Our Partners
Contact Us
R&D
Sustainability
Sustainability
Sustainability at Santen
Ophthalmology
Wellness
Inclusion
Development and Stable Supply of Socially Significant Products and Services
Encouragement of an Organizational Culture that Promotes Value Creation
Strengthening Governance, Contributing to the Realization of Fair and Equal Society
Conservation of the Global Environment
Stakeholder Engagement
Sustainability Library
About Us
About Us
Greetings
CORE PRINCIPLE /
WORLD VISION
Santen 2030
Efforts to Enhance
Patients' Satisfaction
Business Activities
Quality Compliance
Corporate Governance
Overview
Measures To Combat
COVID-19 Infections
Home
Santen Global
Contact
Careers
Santen Global
Japan
Headquarters (Santen Pharmaceutical Co., Ltd.) (Japanese)
Headquarters (Santen Pharmaceutical Co., Ltd.) (English)
Asia
Singapore (Santen Pharmaceutical Asia Pte. Ltd.)
China (Santen Pharmaceutical (China) Co., Ltd.)
Korea (Santen Pharmaceutical Korea, Co., Ltd.)
Taiwan (Taiwan Santen Pharmacuetical Co., Ltd.)
North America
United States (Santen Inc.)
United States (Advanced Vision Science, Inc.)
United States (InnFocus Inc.)
Canada (Santen Canada Inc.)
EMEA (Europe, the Middle
East and Africa)
Armenia
Austria
Belgium & Luxembourg
Bulgaria
Czech Republic
Denmark
Estonia
Finland (Santen Oy)
France (Santen S.A.S.)
Germany (Santen GmbH)
Hungary
Ireland
Italy (Santen Italy s.r.l.)
Kazakhstan
Latvia
The Netherlands
Norway
Poland
Portugal
Romania
Russia (SANTEN LIMITED LIABILITY COMPANY)
Slovakia
Spain (Santen Pharmaceutical Spain, S.L.)
Sweden (SantenPharma AB)
Switzerland (Santen SA)
UK (Santen UK Ltd.)
Ukraine
Uzbekistan
Keyword search
Home
Investors
IR Library
Consolidated Performance
Consolidated Performance
